Literature DB >> 25608673

[Interleukin-22 - friend or foe?].

J Leipe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25608673     DOI： 10.1007/s00393-013-1331-6

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  20 in total

1.  Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation.

Authors:  Renoud J Marijnissen; Marije I Koenders; Ruben L Smeets; Mark H T Stappers; Cheryl Nickerson-Nutter; Leo A B Joosten; Annemieke M H Boots; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2011-10

Review 2.  Interleukin-22: a likely target for treatment of autoimmune diseases.

Authors:  Xuyan Yang; Song Guo Zheng
Journal:  Autoimmun Rev       Date:  2014-01-10       Impact factor: 9.754

Review 3.  Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis.

Authors:  Robert Sabat; Kerstin Wolk
Journal:  J Dtsch Dermatol Ges       Date:  2011-01-21       Impact factor: 5.584

4.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

5.  Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis.

Authors:  Rita Cascão; Rita A Moura; Inês Perpétuo; Helena Canhão; Elsa Vieira-Sousa; Ana F Mourão; Ana M Rodrigues; Joaquim Polido-Pereira; Mário V Queiroz; Henrique S Rosário; Maria M Souto-Carneiro; Luis Graca; João E Fonseca
Journal:  Arthritis Res Ther       Date:  2010-10-20       Impact factor: 5.156

6.  Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.

Authors:  Silke Schmechel; Astrid Konrad; Julia Diegelmann; Jürgen Glas; Martin Wetzke; Ekaterini Paschos; Peter Lohse; Burkhard Göke; Stephan Brand
Journal:  Inflamm Bowel Dis       Date:  2008-02       Impact factor: 5.325

7.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

Review 8.  IL-22, not simply a Th17 cytokine.

Authors:  Sascha Rutz; Céline Eidenschenk; Wenjun Ouyang
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

9.  Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity.

Authors:  Laurindo Ferreira da Rocha; Ângela Luzia Branco Pinto Duarte; Andréa Tavares Dantas; Henrique Ataíde Mariz; Ivan da Rocha Pitta; Suely Lins Galdino; Maira Galdino da Rocha Pitta
Journal:  J Rheumatol       Date:  2012-05-15       Impact factor: 4.666

10.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Margaret Karow; Richard A Flavell
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.